Literature DB >> 34341151

Mild Cognitive Impairment Criteria in Alzheimer's Disease Neuroimaging Initiative: Meeting Biological Expectations.

Ronald C Petersen1.   

Abstract

Entities:  

Year:  2021        PMID: 34341151      PMCID: PMC8480480          DOI: 10.1212/WNL.0000000000012588

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   11.800


× No keyword cloud information.
  9 in total

1.  Neuropsychological subtypes of incident mild cognitive impairment in the Mayo Clinic Study of Aging.

Authors:  Mary M Machulda; Emily S Lundt; Sabrina M Albertson; Walter K Kremers; Michelle M Mielke; David S Knopman; Mark W Bondi; Ronald C Petersen
Journal:  Alzheimers Dement       Date:  2019-05-23       Impact factor: 21.566

2.  Mild cognitive impairment: a concept in evolution.

Authors:  R C Petersen; B Caracciolo; C Brayne; S Gauthier; V Jelic; L Fratiglioni
Journal:  J Intern Med       Date:  2014-03       Impact factor: 8.989

3.  Decision rules guiding the clinical diagnosis of Alzheimer's disease in two community-based cohort studies compared to standard practice in a clinic-based cohort study.

Authors:  David A Bennett; Julie A Schneider; Neelum T Aggarwal; Zoe Arvanitakis; Raj C Shah; Jeremiah F Kelly; Jacob H Fox; Elizabeth J Cochran; Danielle Arends; Anna D Treinkman; Robert S Wilson
Journal:  Neuroepidemiology       Date:  2006-10-10       Impact factor: 3.282

4.  Vitamin E and donepezil for the treatment of mild cognitive impairment.

Authors:  Ronald C Petersen; Ronald G Thomas; Michael Grundman; David Bennett; Rachelle Doody; Steven Ferris; Douglas Galasko; Shelia Jin; Jeffrey Kaye; Allan Levey; Eric Pfeiffer; Mary Sano; Christopher H van Dyck; Leon J Thal
Journal:  N Engl J Med       Date:  2005-04-13       Impact factor: 91.245

Review 5.  Mild cognitive impairment as a diagnostic entity.

Authors:  R C Petersen
Journal:  J Intern Med       Date:  2004-09       Impact factor: 8.989

6.  Natural history of mild cognitive impairment in older persons.

Authors:  D A Bennett; R S Wilson; J A Schneider; D A Evans; L A Beckett; N T Aggarwal; L L Barnes; J H Fox; J Bach
Journal:  Neurology       Date:  2002-07-23       Impact factor: 9.910

7.  Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization.

Authors:  R C Petersen; P S Aisen; L A Beckett; M C Donohue; A C Gamst; D J Harvey; C R Jack; W J Jagust; L M Shaw; A W Toga; J Q Trojanowski; M W Weiner
Journal:  Neurology       Date:  2009-12-30       Impact factor: 9.910

8.  Amnestic MCI in ADNI: Maybe Not Enough Memory Impairment?

Authors:  Kevin Duff
Journal:  Neurology       Date:  2021-08-02       Impact factor: 11.800

9.  Clinicopathologic and 11C-Pittsburgh compound B implications of Thal amyloid phase across the Alzheimer's disease spectrum.

Authors:  Melissa E Murray; Val J Lowe; Neill R Graff-Radford; Amanda M Liesinger; Ashley Cannon; Scott A Przybelski; Bhupendra Rawal; Joseph E Parisi; Ronald C Petersen; Kejal Kantarci; Owen A Ross; Ranjan Duara; David S Knopman; Clifford R Jack; Dennis W Dickson
Journal:  Brain       Date:  2015-03-23       Impact factor: 13.501

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.